Within the first 2 days of treatment, the unfiltered target 2 elicited near normal response patterns for both imposed myopic and hyperopic defocus, opposite in direction in accordance with the difference in sign. Intergroup differences in induced vitreous chamber depth, choroidal thickness, and refractive error changes achieved statistical significance (two-way, repeated-measures ANOVA:
P = 0.0425, 0.0028, and 0.0193, respectively,
Figs. 4A 4B 4C , open symbols;
Table 2 ). In contrast, the response patterns recorded with target 4 do not show any sign dependence. Regardless of whether myopic or hyperopic defocus was imposed, treated eyes showed enhanced vitreous chamber elongation and, consequently, development of myopia (
Fig. 4 , filled symbols;
Table 2 ). Note that the increase in vitreous chamber depth elicited with hyperopic defocus and target 2 was smaller than the increases with both the hyperopic and myopic defocus conditions and target 4 (
P = 0.0011 and 0.0173, respectively;
Fig. 4A ). For target 4, both defocus groups also showed choroidal thinning in treated eyes within the first 2 days of treatment. Thus, interocular differences in choroidal thickness decreased in both groups over this time frame. With imposed myopic defocus, the interocular difference in choroidal thickness continued to decrease over the subsequent 2 days of treatment, whereas with hyperopic defocus, it returned to the pretreatment level
(Fig. 4B) . Corresponding induced refractive error changes were nearly identical in the two defocus groups
(Fig. 4C) . All four groups (each of the two targets combined with each of the two defocus conditions) showed treatment-induced increases in axial length and anterior chamber depth that were greater over the final 2 days compared with the first 2 days of the treatment period
(Figs. 4D 4E) , and while axial length data hinted at sign-dependent differences, they did not reach statistical significance for either target
(Fig. 4D) .